| 6BLR | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | EDO | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes., Wang Y, Sosinowski T, Novikov A, Crawford F, Neau DB, Yang J, Kwok WW, Marrack P, Kappler JW, Dai S, Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1716527115. doi:, 10.1073/pnas.1716527115. PMID:29255035 | ||||||||||||||
| Data retrieval |
![]() |
| View 6BLR in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |